糖尿病患者必须定期监测血糖水平,通常是从指尖采集血液样品,用血糖仪测试,提供患者做出适宜的糖尿病管理决策。美国加州圣地亚哥Dexcom公司研制成功的G5移动连续血糖监测系统获美国FDA批准。它是利用插入皮下的传感器连续测量和监测葡萄糖水平。每5分钟将实时测得结果用无线发送到专用接收 Diabetics must regularly monitor their blood glucose levels, usually blood samples taken from their fingertips and tested with a blood glucose meter, to provide the patient with the appropriate diabetes management decisions. The successful G5 Mobile Continuous Blood Glucose Monitoring System developed by Dexcom Corporation of San Diego, California was approved by the U.S. FDA. It measures and monitors glucose levels continuously using sensors inserted subcutaneously. Real-time measurements are sent wirelessly every 5 minutes to a dedicated receiver